 | • レポートコード：QY2207C0462 • 出版社/出版日：QYResearch / 2022年7月15日 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のフルオキセチンHCLの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフルオキセチンHCLの世界市場のxxx％を占める「純度≥99.5％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「カプセル」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のフルオキセチンHCLの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのフルオキセチンHCL市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのフルオキセチンHCL市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 フルオキセチンHCLのグローバル主要メーカーには、SUANFARMA、Cadila Pharmaceuticals、Palam Pharma、Teva、Zeon Pharma、Dr. Reddy's Laboratories、Shandong Keyuan Pharmaceutical、Apeloa Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 フルオキセチンHCL市場は、種類と用途によって区分されます。世界のフルオキセチンHCL市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 純度≥99.5％、純度≥99.9％ 【用途別セグメント】 カプセル、錠剤、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - フルオキセチンHCL製品概要 - 種類別市場（純度≥99.5％、純度≥99.9％） - 用途別市場（カプセル、錠剤、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のフルオキセチンHCL販売量予測2017-2028 - 世界のフルオキセチンHCL売上予測2017-2028 - フルオキセチンHCLの地域別販売量 - フルオキセチンHCLの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別フルオキセチンHCL販売量 - 主要メーカー別フルオキセチンHCL売上 - 主要メーカー別フルオキセチンHCL価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（純度≥99.5％、純度≥99.9％） - フルオキセチンHCLの種類別販売量 - フルオキセチンHCLの種類別売上 - フルオキセチンHCLの種類別価格 ・用途別市場規模（カプセル、錠剤、その他） - フルオキセチンHCLの用途別販売量 - フルオキセチンHCLの用途別売上 - フルオキセチンHCLの用途別価格 ・北米市場 - 北米のフルオキセチンHCL市場規模（種類別、用途別） - 主要国別のフルオキセチンHCL市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのフルオキセチンHCL市場規模（種類別、用途別） - 主要国別のフルオキセチンHCL市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のフルオキセチンHCL市場規模（種類別、用途別） - 主要国別のフルオキセチンHCL市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のフルオキセチンHCL市場規模（種類別、用途別） - 主要国別のフルオキセチンHCL市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのフルオキセチンHCL市場規模（種類別、用途別） - 主要国別のフルオキセチンHCL市場規模（トルコ、サウジアラビア） ・企業情報 SUANFARMA、Cadila Pharmaceuticals、Palam Pharma、Teva、Zeon Pharma、Dr. Reddy's Laboratories、Shandong Keyuan Pharmaceutical、Apeloa Pharmaceutical ・産業チェーン及び販売チャネル分析 - フルオキセチンHCLの産業チェーン分析 - フルオキセチンHCLの原材料 - フルオキセチンHCLの生産プロセス - フルオキセチンHCLの販売及びマーケティング - フルオキセチンHCLの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - フルオキセチンHCLの産業動向 - フルオキセチンHCLのマーケットドライバー - フルオキセチンHCLの課題 - フルオキセチンHCLの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Fluoxetine HCL Market
Due to the COVID-19 pandemic, the global Fluoxetine HCL market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99.5% accounting for % of the Fluoxetine HCL global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Capsule segment is altered to an % CAGR throughout this forecast period.
China Fluoxetine HCL market size is valued at US$ million in 2021, while the US and Europe Fluoxetine HCL are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fluoxetine HCL landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Fluoxetine HCL include SUANFARMA, Cadila Pharmaceuticals, Palam Pharma, Teva, Zeon Pharma, Dr. Reddy’s Laboratories, Shandong Keyuan Pharmaceutical and Apeloa Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Fluoxetine HCL capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Fluoxetine HCL by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Fluoxetine HCL Scope and Segment
Fluoxetine HCL market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Fluoxetine HCL market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99.5%
Purity ≥99.9%
Segment by Application
Capsule
Tablet
Other
By Company
SUANFARMA
Cadila Pharmaceuticals
Palam Pharma
Teva
Zeon Pharma
Dr. Reddy’s Laboratories
Shandong Keyuan Pharmaceutical
Apeloa Pharmaceutical
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Fluoxetine HCL Product Introduction
1.2 Market by Type
1.2.1 Global Fluoxetine HCL Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99.5%
1.2.3 Purity ≥99.9%
1.3 Market by Application
1.3.1 Global Fluoxetine HCL Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Capsule
1.3.3 Tablet
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Fluoxetine HCL Production
2.1 Global Fluoxetine HCL Production Capacity (2017-2028)
2.2 Global Fluoxetine HCL Production by Region: 2017 VS 2021 VS 2028
2.3 Global Fluoxetine HCL Production by Region
2.3.1 Global Fluoxetine HCL Historic Production by Region (2017-2022)
2.3.2 Global Fluoxetine HCL Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
3 Global Fluoxetine HCL Sales in Volume & Value Estimates and Forecasts
3.1 Global Fluoxetine HCL Sales Estimates and Forecasts 2017-2028
3.2 Global Fluoxetine HCL Revenue Estimates and Forecasts 2017-2028
3.3 Global Fluoxetine HCL Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Fluoxetine HCL Sales by Region
3.4.1 Global Fluoxetine HCL Sales by Region (2017-2022)
3.4.2 Global Sales Fluoxetine HCL by Region (2023-2028)
3.5 Global Fluoxetine HCL Revenue by Region
3.5.1 Global Fluoxetine HCL Revenue by Region (2017-2022)
3.5.2 Global Fluoxetine HCL Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Fluoxetine HCL Production Capacity by Manufacturers
4.2 Global Fluoxetine HCL Sales by Manufacturers
4.2.1 Global Fluoxetine HCL Sales by Manufacturers (2017-2022)
4.2.2 Global Fluoxetine HCL Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Fluoxetine HCL in 2021
4.3 Global Fluoxetine HCL Revenue by Manufacturers
4.3.1 Global Fluoxetine HCL Revenue by Manufacturers (2017-2022)
4.3.2 Global Fluoxetine HCL Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Fluoxetine HCL Revenue in 2021
4.4 Global Fluoxetine HCL Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Fluoxetine HCL Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Fluoxetine HCL Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Fluoxetine HCL Sales by Type
5.1.1 Global Fluoxetine HCL Historical Sales by Type (2017-2022)
5.1.2 Global Fluoxetine HCL Forecasted Sales by Type (2023-2028)
5.1.3 Global Fluoxetine HCL Sales Market Share by Type (2017-2028)
5.2 Global Fluoxetine HCL Revenue by Type
5.2.1 Global Fluoxetine HCL Historical Revenue by Type (2017-2022)
5.2.2 Global Fluoxetine HCL Forecasted Revenue by Type (2023-2028)
5.2.3 Global Fluoxetine HCL Revenue Market Share by Type (2017-2028)
5.3 Global Fluoxetine HCL Price by Type
5.3.1 Global Fluoxetine HCL Price by Type (2017-2022)
5.3.2 Global Fluoxetine HCL Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Fluoxetine HCL Sales by Application
6.1.1 Global Fluoxetine HCL Historical Sales by Application (2017-2022)
6.1.2 Global Fluoxetine HCL Forecasted Sales by Application (2023-2028)
6.1.3 Global Fluoxetine HCL Sales Market Share by Application (2017-2028)
6.2 Global Fluoxetine HCL Revenue by Application
6.2.1 Global Fluoxetine HCL Historical Revenue by Application (2017-2022)
6.2.2 Global Fluoxetine HCL Forecasted Revenue by Application (2023-2028)
6.2.3 Global Fluoxetine HCL Revenue Market Share by Application (2017-2028)
6.3 Global Fluoxetine HCL Price by Application
6.3.1 Global Fluoxetine HCL Price by Application (2017-2022)
6.3.2 Global Fluoxetine HCL Price Forecast by Application (2023-2028)
7 North America
7.1 North America Fluoxetine HCL Market Size by Type
7.1.1 North America Fluoxetine HCL Sales by Type (2017-2028)
7.1.2 North America Fluoxetine HCL Revenue by Type (2017-2028)
7.2 North America Fluoxetine HCL Market Size by Application
7.2.1 North America Fluoxetine HCL Sales by Application (2017-2028)
7.2.2 North America Fluoxetine HCL Revenue by Application (2017-2028)
7.3 North America Fluoxetine HCL Sales by Country
7.3.1 North America Fluoxetine HCL Sales by Country (2017-2028)
7.3.2 North America Fluoxetine HCL Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Fluoxetine HCL Market Size by Type
8.1.1 Europe Fluoxetine HCL Sales by Type (2017-2028)
8.1.2 Europe Fluoxetine HCL Revenue by Type (2017-2028)
8.2 Europe Fluoxetine HCL Market Size by Application
8.2.1 Europe Fluoxetine HCL Sales by Application (2017-2028)
8.2.2 Europe Fluoxetine HCL Revenue by Application (2017-2028)
8.3 Europe Fluoxetine HCL Sales by Country
8.3.1 Europe Fluoxetine HCL Sales by Country (2017-2028)
8.3.2 Europe Fluoxetine HCL Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Fluoxetine HCL Market Size by Type
9.1.1 Asia Pacific Fluoxetine HCL Sales by Type (2017-2028)
9.1.2 Asia Pacific Fluoxetine HCL Revenue by Type (2017-2028)
9.2 Asia Pacific Fluoxetine HCL Market Size by Application
9.2.1 Asia Pacific Fluoxetine HCL Sales by Application (2017-2028)
9.2.2 Asia Pacific Fluoxetine HCL Revenue by Application (2017-2028)
9.3 Asia Pacific Fluoxetine HCL Sales by Region
9.3.1 Asia Pacific Fluoxetine HCL Sales by Region (2017-2028)
9.3.2 Asia Pacific Fluoxetine HCL Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Fluoxetine HCL Market Size by Type
10.1.1 Latin America Fluoxetine HCL Sales by Type (2017-2028)
10.1.2 Latin America Fluoxetine HCL Revenue by Type (2017-2028)
10.2 Latin America Fluoxetine HCL Market Size by Application
10.2.1 Latin America Fluoxetine HCL Sales by Application (2017-2028)
10.2.2 Latin America Fluoxetine HCL Revenue by Application (2017-2028)
10.3 Latin America Fluoxetine HCL Sales by Country
10.3.1 Latin America Fluoxetine HCL Sales by Country (2017-2028)
10.3.2 Latin America Fluoxetine HCL Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Fluoxetine HCL Market Size by Type
11.1.1 Middle East and Africa Fluoxetine HCL Sales by Type (2017-2028)
11.1.2 Middle East and Africa Fluoxetine HCL Revenue by Type (2017-2028)
11.2 Middle East and Africa Fluoxetine HCL Market Size by Application
11.2.1 Middle East and Africa Fluoxetine HCL Sales by Application (2017-2028)
11.2.2 Middle East and Africa Fluoxetine HCL Revenue by Application (2017-2028)
11.3 Middle East and Africa Fluoxetine HCL Sales by Country
11.3.1 Middle East and Africa Fluoxetine HCL Sales by Country (2017-2028)
11.3.2 Middle East and Africa Fluoxetine HCL Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 SUANFARMA
12.1.1 SUANFARMA Corporation Information
12.1.2 SUANFARMA Overview
12.1.3 SUANFARMA Fluoxetine HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 SUANFARMA Fluoxetine HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 SUANFARMA Recent Developments
12.2 Cadila Pharmaceuticals
12.2.1 Cadila Pharmaceuticals Corporation Information
12.2.2 Cadila Pharmaceuticals Overview
12.2.3 Cadila Pharmaceuticals Fluoxetine HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Cadila Pharmaceuticals Fluoxetine HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Cadila Pharmaceuticals Recent Developments
12.3 Palam Pharma
12.3.1 Palam Pharma Corporation Information
12.3.2 Palam Pharma Overview
12.3.3 Palam Pharma Fluoxetine HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Palam Pharma Fluoxetine HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Palam Pharma Recent Developments
12.4 Teva
12.4.1 Teva Corporation Information
12.4.2 Teva Overview
12.4.3 Teva Fluoxetine HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Teva Fluoxetine HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Teva Recent Developments
12.5 Zeon Pharma
12.5.1 Zeon Pharma Corporation Information
12.5.2 Zeon Pharma Overview
12.5.3 Zeon Pharma Fluoxetine HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Zeon Pharma Fluoxetine HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Zeon Pharma Recent Developments
12.6 Dr. Reddy’s Laboratories
12.6.1 Dr. Reddy’s Laboratories Corporation Information
12.6.2 Dr. Reddy’s Laboratories Overview
12.6.3 Dr. Reddy’s Laboratories Fluoxetine HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Dr. Reddy’s Laboratories Fluoxetine HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Dr. Reddy’s Laboratories Recent Developments
12.7 Shandong Keyuan Pharmaceutical
12.7.1 Shandong Keyuan Pharmaceutical Corporation Information
12.7.2 Shandong Keyuan Pharmaceutical Overview
12.7.3 Shandong Keyuan Pharmaceutical Fluoxetine HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Shandong Keyuan Pharmaceutical Fluoxetine HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Shandong Keyuan Pharmaceutical Recent Developments
12.8 Apeloa Pharmaceutical
12.8.1 Apeloa Pharmaceutical Corporation Information
12.8.2 Apeloa Pharmaceutical Overview
12.8.3 Apeloa Pharmaceutical Fluoxetine HCL Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Apeloa Pharmaceutical Fluoxetine HCL Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Apeloa Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Fluoxetine HCL Industry Chain Analysis
13.2 Fluoxetine HCL Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Fluoxetine HCL Production Mode & Process
13.4 Fluoxetine HCL Sales and Marketing
13.4.1 Fluoxetine HCL Sales Channels
13.4.2 Fluoxetine HCL Distributors
13.5 Fluoxetine HCL Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Fluoxetine HCL Industry Trends
14.2 Fluoxetine HCL Market Drivers
14.3 Fluoxetine HCL Market Challenges
14.4 Fluoxetine HCL Market Restraints
15 Key Finding in The Global Fluoxetine HCL Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer